Assistant Professor
Eindhoven University of Technology
Eindhoven, Netherlands
Roy van der Meel is a biomedical engineer specialized in nanomedicine and RNA therapeutics. After obtaining a PhD from Utrecht University under guidance of Wim Hennink and Gert Storm, he moved to Pieter Cullis’ lab at the University of British Columbia. There, he gained extensive experience with lipid nanoparticle technology that has enabled the first siRNA therapeutic Onpattro® and the COVID-19 mRNA vaccines. In 2019, he was recruited to Eindhoven University of Technology by Willem Mulder and appointed Assistant Professor in the Precision Medicine group. His current research focuses on establishing platform nanotechnology for delivering RNA to specific immune cells.
Disclosure information not submitted.
Friday, July 12, 2024
12:30 PM - 2:00 PM CET
